Adverse drug reaction and causality assessment scales

Lung India

Volumn 28, Issue 2, 2011, Pages 152-153

  Zaki, Syed Ahmed ^a  

^a LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADVERSE OUTCOME; CAUSAL ATTRIBUTION; CLINICAL PRACTICE; HOSPITAL ADMISSION; HUMAN; LETTER; METHODOLOGY; MORBIDITY; MORTALITY; UNSPECIFIED SIDE EFFECT;

EID: 79960243952     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.80343     Document Type: Letter

References (4)

1. Gupta KB, Kumar V, Vishvkarma S, Shandily R. Isoniazid-induced alopecia. Lung India 2011;28:60-61.
2. Gulati S, Paljor HP, Mahajan R, Goel P. Erythema multiforme due to antitubercular drugs. Lung India 2011;28:76.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
4. The use of the WHO-UMC system for standardised case causality assessment. Accessed from: http://www.who-umc.org/graphics/4409.pdf [last accessed on 2011 Feb 12].